Skip to content
20-F

Annual Report (Foreign)

Kazia Therapeutics Limited. KZIA

0001193125-25-272284

← back to feed
Filed
Nov 7, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Jun 30, 2025 809.42M sh
Dividends Paid FY 2025 · Jun 30, 2025 0
Operating Cash Flow FY 2025 · Jun 30, 2025 −13.28M
Operating Cash Flow FY 2025 · Jun 30, 2024 −9.58M
Operating Cash Flow FY 2025 · Jun 30, 2023 −15.16M
Cash And Equivalents FY 2025 · Jun 30, 2025 4.35M
Cash And Equivalents FY 2025 · Jun 30, 2024 1.66M
Cash And Equivalents restated FY 2025 · Jun 30, 2023 5.24M
Cash And Equivalents restated FY 2025 · Jun 30, 2022 7.36M
Current Liabilities FY 2025 · Jun 30, 2025 14.05M
Current Liabilities FY 2025 · Jun 30, 2024 25.8M
Total Liabilities FY 2025 · Jun 30, 2025 14.36M
Total Liabilities FY 2025 · Jun 30, 2024 31.6M
Current Assets FY 2025 · Jun 30, 2025 4.93M
Current Assets FY 2025 · Jun 30, 2024 6.15M
Total Assets FY 2025 · Jun 30, 2025 6.06M
Total Assets FY 2025 · Jun 30, 2024 21.59M
Eps Diluted FY 2025 · Jun 30, 2025 −0.04
Eps Diluted FY 2025 · Jun 30, 2024 −0.10
Eps Diluted FY 2025 · Jun 30, 2023 −0.11
Eps Basic FY 2025 · Jun 30, 2025 −0.04
Eps Basic FY 2025 · Jun 30, 2024 −0.10
Eps Basic FY 2025 · Jun 30, 2023 −0.11
Sga Expense FY 2025 · Jun 30, 2025 8.72M
Sga Expense FY 2025 · Jun 30, 2024 13.56M
Sga Expense FY 2025 · Jun 30, 2023 8.58M
Rd Expense FY 2025 · Jun 30, 2025 7.33M
Rd Expense FY 2025 · Jun 30, 2024 17.38M
Rd Expense FY 2025 · Jun 30, 2023 15.56M
Net Income FY 2025 · Jun 30, 2025 −20.7M
Net Income FY 2025 · Jun 30, 2024 −26.78M
Net Income restated FY 2025 · Jun 30, 2023 −20.47M
Revenue FY 2025 · Jun 30, 2025 42K
Revenue FY 2025 · Jun 30, 2024 2.31M
Revenue FY 2025 · Jun 30, 2023 0